{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:02:49Z","timestamp":1770433369232,"version":"3.49.0"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1918,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1476-5829.2010.00217.x","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T11:24:16Z","timestamp":1274095456000},"page":"138-152","source":"Crossref","is-referenced-by-count":41,"title":["A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours"],"prefix":"10.1111","volume":"8","author":[{"given":"K. M.","family":"Rassnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. B.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Flory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Kiselow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Intile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. K.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Balkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2460\/javma.2004.224.236","article-title":"Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs","volume":"224","author":"Simpson","year":"2004","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1939-1676.1996.tb02084.x","article-title":"A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs","volume":"10","author":"Al-Sarraf","year":"1996","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5326\/0380071","article-title":"Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision","volume":"38","author":"Weisse","year":"2002","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1748-5827.1973.tb06891.x","article-title":"The prognosis following surgical removal of mastocytomas in dogs","volume":"14","author":"Bostock","year":"1973","journal-title":"Journal of Small Animal Practice"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/030098588402100503","article-title":"Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs","volume":"21","author":"Patnaik","year":"1984","journal-title":"Veterinary Pathology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2460\/javma.1988.193.08.936","article-title":"Prognostic factors for radiation treatment of mast cell tumor in 85 dogs","volume":"193","author":"Turrel","year":"1988","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/vr.154.24.743","article-title":"Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection","volume":"154","author":"Murphy","year":"2004","journal-title":"Veterinary Record"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1939-1676.1999.tb02217.x","article-title":"Treatment of canine mast cell tumors with CCNU (lomustine)","volume":"13","author":"Rassnick","year":"1999","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1939-1676.1994.tb03259.x","article-title":"Response of canine mast cell tumors to treatment with oral prednisone","volume":"8","author":"McCaw","year":"1994","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2460\/javma.232.1.53","article-title":"Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs","volume":"232","author":"Stanclift","year":"2008","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1939-1676.1999.tb01468.x","article-title":"Prednisone and vinblastine chemotherapy for canine mast cell tumor-41 cases (1992-1997)","volume":"13","author":"Thamm","year":"1999","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2460\/ajvr.68.11.1246","article-title":"Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs","volume":"68","author":"Henry","year":"2007","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1939-1676.2008.0195.x","article-title":"Efficacy of vinblastine for treatment of canine mast cell tumors","volume":"22","author":"Rassnick","year":"2008","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-08-1860","article-title":"Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision","volume":"15","author":"London","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1939-1676.2008.0190.x","article-title":"Masitinib is safe and effective for the treatment of canine mast cell tumors","volume":"22","author":"Hahn","year":"2008","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1748-5827.2009.00732.x","article-title":"Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases","volume":"50","author":"Taylor","year":"2009","journal-title":"Journal of Small Animal Practice"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1939-1676.2004.tb00138.x","article-title":"Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs","volume":"18","author":"Kristal","year":"2004","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1476-5829.2008.00175.x","article-title":"Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs","volume":"7","author":"Intile","year":"2009","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1476-5829.2009.00197.x","article-title":"Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)","volume":"7","author":"Hosoya","year":"2009","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5829.2007.00147.x","article-title":"Dose-escalating vinblastine for the treatment of canine mast cell tumour","volume":"6","author":"Vickery","year":"2008","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1476-5829.2006.00125.x","article-title":"Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997-2004)","volume":"5","author":"Camps-Palau","year":"2007","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1292\/jvms.68.581","article-title":"Outcome and prognostic factors following adjuvant prednisone\/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.","volume":"68","author":"Thamm","year":"2006","journal-title":"Journal of Veterinary Medical Science"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1476-5829.2007.00135.x","article-title":"Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours","volume":"5","author":"Hayes","year":"2007","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose: a critical factor in cancer chemotherapy","volume":"69","author":"Frei","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB25|cit25","first-page":"2027","article-title":"The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity","volume":"4","author":"Frei","year":"1998","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1939-1676.2008.0196.x","article-title":"Phase I dose escalation of single-agent vinblastine in dogs","volume":"22","author":"Bailey","year":"2008","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1354\/vp.44-3-335","article-title":"Mitotic index is predictive for survival for canine cutaneous mast cell tumors","volume":"44","author":"Romansik","year":"2007","journal-title":"Veterinary Pathology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5810.2004.0053b.x","article-title":"Veterinary co-operative oncology group common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.","volume":"2","year":"2004","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1939-1676.1997.tb00484.x","article-title":"Vincristine therapy for mast cell tumors in dogs","volume":"11","author":"McCaw","year":"1997","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5326\/0400124","article-title":"Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors","volume":"40","author":"Davies","year":"2004","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1939-1676.2007.tb02940.x","article-title":"Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study","volume":"21","author":"Chretin","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cvsm.2006.11.009","article-title":"Interpretation of liver enzymes","volume":"37","author":"Center","year":"2007","journal-title":"Veterinary Clinics of North America Small Animal Practice"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1476-5829.2009.00190.x","article-title":"Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases","volume":"7","author":"Cooper","year":"2009","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/030098589202900502","article-title":"Correlation between histologic diagnosis mean nucleolar organizer region count and prognosis in canine mammary tumors","volume":"29","author":"Bostock","year":"1992","journal-title":"Veterinary Pathology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/030098589403100602","article-title":"Prognosis of canine mast cell tumors: a comparison of three methods","volume":"31","author":"Simoes","year":"1994","journal-title":"Veterinary Pathology"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1740-8261.2002.tb01023.x","article-title":"Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.","volume":"43","author":"Chaffin","year":"2002","journal-title":"Veterinary Radiology and Ultrasound"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/vr.158.9.287","article-title":"Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours","volume":"158","author":"Murphy","year":"2006","journal-title":"Veterinary Record"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2460\/javma.2000.216.222","article-title":"Visceral mast cell tumors in dogs: 10 cases (1982-1997)","volume":"216","author":"Takahashi","year":"2000","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1476-5829.2010.00217.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1748-5827.2006.00045.x","article-title":"Lomustine for the treatment of gastrointestinal mast cell tumour in a dog","volume":"47","author":"Baldi","year":"2006","journal-title":"Journal of Small Animal Practice"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2010.00217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-5829.2010.00217.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:27:40Z","timestamp":1740090460000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2010.00217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":39,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2010.00217.x","relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}